• Affordable Cancer Care for Indian Patients • Deep understanding of Disease Biology for • new target Discovery • Development of Indian Patient Centric Preclinical Models • Natural Product driven Adjunct Cancer Therapy
Current Lead: Smac Mimetic (S016-1348) or IAP inhibitor active against chemotherapy resistant cancer
Existing Facilities: 30 cell line repository across most solid tumors, Nude and NOD-SCID animal facility
Recent Publications: Oncoimmunology (2016), Carcinogenesis (2016), Oncogene (2017), Molecular Cancer Research (2016), Oncotarget (2016), Molecular Cancer Therapy (2017), Carcinogenesis (2019), Hematologica (2019), Nature Communications (2020), Epigenetics (2020)
Dr. ARUN KUMAR TRIVEDI
Senior Principal Scientist
CSIR-CDRI
Dr. DIPAK DATTA
Dr. DIBYENDU BANERJEE
Principal Scientist
Dr. JAYANTA SARKAR
Dr. NEERAJ JAIN
Ramalingaswami Fellow
Dr. SABYASACHI SANYAL
Chief Scientist
Dr. SMRATI BHADAURIA
Dr. DURGA PRASAD MISHRA
Dr. MONIKA SACHDEV
Dr. Madhav Nilakanth Mugale